Veracyte
VCYT
#4742
Rank
NZ$3.68 B
Marketcap
NZ$45.63
Share price
-0.16%
Change (1 day)
-35.84%
Change (1 year)

Earnings for Veracyte (VCYT)

Earnings in 2026 (TTM): NZ$0.20 Billion

According to Veracyte's latest financial reports the company's current earnings are NZ$0.56 Billion. In 2025 the company made an earning of NZ$0.12 Billion, an increase over its 2024 earnings that were of NZ$43.8 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Veracyte from 2013 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.20 B61.93%
2025 NZ$0.12 B184.15%
2024 NZ$43.8 M-131.34%
2023 -NZ$0.14 Billion111.42%
2022 -NZ$66.13 Million-55.5%
2021 -NZ$0.15 Billion134.74%
2020 -NZ$63.3 Million190.89%
2019 -NZ$21.76 Million-43.33%
2018 -NZ$38.4 Million-23.78%
2017 -NZ$50.37 Million-3.51%
2016 -NZ$52.2 Million-14.17%
2015 -NZ$60.82 Million15.17%
2014 -NZ$52.81 Million14.15%
2013 -NZ$46.27 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Exact Sciences
EXAS
-NZ$0.34 Billion-257.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
-NZ$0.71 Billion-432.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Biocept
BIOC
-NZ$63.82 Million-130.14%๐Ÿ‡บ๐Ÿ‡ธ USA